Perrigo Company Plc
A maker of over-the-counter self-care products, Perrigo supplies store-brand medicines to retailers and also sells its own brands like Opill®, Mederma®, Compeed®, and Solpadeine® across North America and Europe. The company traces back to 1887, when Michigan general-store owner Luther Perrigo began packaging medicines and household goods for other country stores — and pioneered the private-label idea by printing each store's own name on the labels. The company still bears his name today.
Granted 80.0K · Bought 7.6K · Sold 35.0K
Granted 171.3K · Bought 25.0K
Granted 41.3K · Bought 35.4K
Granted 104.0K · Bought 8.0K
Granted 6.6K
Granted 23.4K · Bought 3.0K
Granted 31.9K · Bought 27.5K
Granted 68.6K · Bought 13.4K
Granted 41.3K · Bought 13.0K
Granted 73.1K · Sold 29.3K
Granted 40.4K
Granted 53.3K
Granted 33.0K
Granted 43.2K · Sold 9.0K
Granted 23.1K
Granted 34.8K · Sold 2.4K
Granted 13.4K · Bought 6.1K
Bought 2.8K
Granted 31.5K
Granted 22.8K
Granted 28.8K
Granted 15.9K
Granted 36.7K · Sold 30.5K
Granted 33.0K · Sold 17.6K
Granted 10.4K
Granted 10.6K
Granted 6.7K · Bought 1.0K
Granted 9.3K
Granted 7.0K · Bought 1.3K
Granted 23.1K · Sold 9.0K
Granted 7.3K
Granted 262.0K · Sold 197.6K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Andersen SvendEVP & President CHCI · 23 transactions | +467.8% | 175.6Kas of Aug 2024 | 80.0K | 7.6K | 35.0K |
| Lockwood-Taylor PatrickFormer CEO and director · 23 transactions | — | 123.2K | 171.3K | 25.0K | — |
| Parker Geoffrey M.Director · 18 transactions | — | 122.8K | 41.3K | 35.4K | — |
| Bezerra Eduardo GuaritaEVP & Chief Financial Officer · 26 transactions | — | 84.7K | 104.0K | 8.0K | — |
| Samuels Theodore R. IIDirector · 1 transaction | +8.6% | 83.0Kas of May 2022 | 6.6K | — | — |
| Kingma Todd WExecutive VP, General Counsel · 13 transactions | — | 64.2Kas of Jun 2024 | 23.4K | 3.0K | — |
| Silcock RaymondEVP, Chief Financial Officer · 9 transactions | +483.4% | 59.5Kas of Apr 2022 | 31.9K | 27.5K | — |
| Willis RobertEVP & CHRO · 52 transactions | +1669.7% | 52.4K | 68.6K | 13.4K | — |
| Alford Bradley ADirector · 13 transactions | +314.1% | 45.5K | 41.3K | 13.0K | — |
| Janish Ronald CraigEVP, Gbl Ops & SC & CTO · 36 transactions | +148.9% | 40.6Kas of Jun 2025 | 73.1K | — | 29.3K |
| O'Connor DonalDirector · 10 transactions | +167.1% | 39.1K | 40.4K | — | — |
| Ashford Orlando DDirector · 12 transactions | — | 27.7K | 53.3K | — | — |
| Karaboutis AdrianaDirector · 8 transactions | +164.5% | 27.6Kas of May 2025 | 33.0K | — | — |
| Dillard James E IIIEVP & President CSCA · 19 transactions | +155.3% | 25.1Kas of Mar 2023 | 43.2K | — | 9.0K |
| Mann Erica LDirector · 6 transactions | +280.8% | 21.7Kas of May 2024 | 23.1K | — | — |
| Quinn GrainneEVP, Chief Medical Officer · 25 transactions | +212.7% | 21.1Kas of Apr 2024 | 34.8K | — | 2.4K |
| Ives AlisonEVP & Chief Scientific Officer · 26 transactions | — | 18.5Kas of Jul 2024 | 13.4K | 6.1K | — |
| Classon Rolf ADirector · 1 transaction | +19.1% | 17.4Kas of Dec 2021 | — | 2.8K | — |
| Manzone AlbertDirector · 8 transactions | — | 16.4K | 31.5K | — | — |
| Brown Julia MDirector · 6 transactions | — | 15.3K | 22.8K | — | — |
| Khoury RobertoEVP and President of CSCI · 10 transactions | — | 13.1K | 28.8K | — | — |
| Hanson KyleEVP & General Counsel · 6 transactions | — | 11.1Kas of Apr 2024 | 15.9K | — | — |
| Farrington ThomasEVP and CIO · 26 transactions | -34.6% | 10.7Kas of Apr 2024 | 36.7K | — | 30.5K |
| Kindler Jeffrey BDirector · 9 transactions | -3.8% | 10.6Kas of May 2025 | 33.0K | — | 17.6K |
| Samuelson JonasDirector · 4 transactions | — | 8.9K | 10.4K | — | — |
| Ball DavidEVP & CBDO · 4 transactions | — | 7.8K | 10.6K | — | — |
| Atkinson CharlesEVP, General Counsel & Sec. · 3 transactions | — | 7.7K | 6.7K | 1.0K | — |
| Schmelter TrionaEVP & President CSCA · 6 transactions | — | 6.7Kas of Jun 2025 | 9.3K | — | — |
| Lennox AbigailEVP and CSO · 5 transactions | — | 6.6K | 7.0K | 1.3K | — |
| Doyle Katherine C.Director · 7 transactions | +105% | 6.0Kas of Sep 2024 | 23.1K | — | 9.0K |
| Egan Kevin FrancisDirector · 2 transactions | — | 3.8K | 7.3K | — | — |
| Kessler Murray SCEO, Director · 17 transactions | -95.1% | 2.7Kas of May 2023 | 262.0K | — | 197.6K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -186.3K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.